DNA damage-induced cell death: Lessons from the central nervous system

Cell Research

Volumn 18, Issue 1, 2008, Pages 17-26

  Borges, Helena Lobo ^a,b   Linden, Rafael ^b   Wang, Jean Y J ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Apoptosis; ATM; Ionizing radiation; Neonatal retina; Neuroblasts; P53; Phosphorylation

Indexed keywords

EID: 38049136456     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2007.110     Document Type: Article

References (79)

1. Rich T, Allen RL, Wyllie AH. Defying death after DNA damage. Nature 2000; 407:777-783.
2. Blank M, Shiloh Y. Programs for cell death: apoptosis is only one way to go. Cell Cycle 2007; 6:686-695.
3. Roos WP, Kaina B. DNA damage-induced cell death by apoptosis. Trends Mol Med 2006; 12:440-450.
4. Bentle MS, Bey EA, Dong Y, Reinicke KE, Boothman DA. New tricks for old drugs: the anticarcinogenic potential of DNA repair inhibitors. J Mol Histol 2006; 37:203-218.
5. Michod D, Widmann C. DNA-damage sensitizers: potential new therapeutical tools to improve chemotherapy. Crit Rev Oncol Hematol 2007; 63:160-171.
6. Wang JY, Cho SK. Coordination of repair, checkpoint, and cell death responses to DNA damage. Adv Protein Chem 2004; 69:101-135.
7. Ben-Porath I, Weinberg RA. The signals and pathways activating cellular senescence. Int J Biochem Cell Biol 2005; 37:961-976.
8. Jeggo P, Lobrich M. Radiation-induced DNA damage responses. Radiat Prot Dosimetry 2006; 122:124-127.
9. Lavin MF, Kozlov S. ATM activation and DNA damage response. Cell Cycle 2007; 6:931-942.
10. Bartek J, Lukas J. DNA damage checkpoints: from initiation to recovery or adaptation. Curr Opin Cell Biol 2007; 19:238-245.
11. Rudolph J. Inhibiting transient protein-protein interactions: lessons from the Cdc25 protein tyrosine phosphatases. Nat Rev Cancer 2001; 7:202-211.
12. Boutros R, Lobjois V, Ducommun B. CDC25 phosphatases in cancer cells: key players? Good targets? Nat Rev Cancer 2001; 7:495-507.
13. Harrison JC, Haber JE. Surviving the breakup: the DNA damage checkpoint. Annu Rev Genet 2006; 40:209-235.
14. Mansilla S, Bataller M, Portugal J. Mitotic catastrophe as a consequence of chemotherapy. Anticancer Agents Med Chem 2006; 6:589-602.
15. Short SC, Bourne S, Martindale C, Woodcock M, Jackson SP. DNA damage responses at low radiation doses. Radiat Res 2005; 164:292-302.
16. Lou Z, Chen J. Cellular senescence and DNA repair. Exp Cell Res 2006; 312:2641-2646.
17. Hurley PJ, Bunz F. ATM and ATR: components of an integrated circuit. Cell Cycle 2007; 6:414-417.
18. Chen Y, Zhao X. Shaping limbs by apoptosis. J Exp Zool 1998; 282:691-702.
19. Kumar S. Caspase function in programmed cell death. Cell Death Differ 2007; 14:32-43.
20. Domingos PM, Steller H. Pathways regulating apoptosis during patterning and development. Curr Opin Genet Dev 2007; 17:294-299.
21. Schumacher B, Hofmann K, Boulton S, Gartner A. The C. elegans homolog of the p53 tumor suppressor is required for DNA damage-induced apoptosis. Curr Biol 2001; 11:1722-1727.
22. Schumacher B, Schertet C, Wittenburg N, et al. C. elegans ced13 can promote apoptosis and is induced in response to DNA damage. Cell Death Differ 2005; 12:153-161.
23. Salinas LS, Maldonado E, Navarro RE. Stress-induced germ cell apoptosis by a p53 independent pathway in Caenorhabditis elegans. Cell Death Differ 2006; 13:2129-2139.
24. Yu J, Zhang L. No PUMA, no death: implications for p53-dependent apoptosis. Cancer Cell 2003; 4:248-249.
25. Abu-Qare AW, Abou-Donia MB. Biomarkers of apoptosis: release of cytochrome c, activation of caspase-3, induction of 8-hydroxy-2′- deoxyguanosine, increased 3-nitrotyrosine, and alteration of p53 gene. J Toxicol Environ Health B Crit Rev 2001; 4:313-332.
26. Hajra KM, Liu JR. Apoptosome dysfunction in human cancer. Apoptosis 2004; 9:691-704.
27. Flores ER, Tsai KY, Crowley D, et al. p63 and p73 are required for p53-dependent apoptosis in response to DNA damage. Nature 2002; 416:560-564.
28. Deyoung MP, Ellisen LW. p63 and p73 in human cancer: defining the network. Oncogene 2007; 26:5169-5183.
29. Lu X, Ma O, Nguyen TA, Jones SN, Oren M, Donehower LA. The Wipl phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop. Cancer Cell 2001; 12:342-354.
30. Aylon Y, Oren M. Living with p53, dying of p53. Cell 2007; 130:597-600.
31. Lahav G, Rosenfeld N, Sigal A, et al. Dynamics of the p53-Mdm2 feedback loop in individual cells. Nat Genet 2004; 36:147-150.
32. He L, He X, Lim LP, et al. A microRNA component of the p53 tumour suppressor network. Nature 2007; 447:1130-1134.
33. Raver-Shapira N, Marciano E, Meiri E, et al. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell 2007; 26:731-743.
34. Cande C, Cecconi F, Dessen P, Kroemer G. Apoptosis-inducing factor (AIF): key to the conserved caspase-independent pathways of cell death? J Cell Sci 2002; 115:4727-4734.
35. Lorenzo HK, Susin SA, Penninger J, Kroemer G. Apoptosis inducing factor (AIF): aphylogenetically old, caspase-independent effector of cell death. Cell Death Differ 1999; 6:516-524.
36. Kerr JF. History of the events leading to the formulation of the apoptosis concept. Toxicology 2002; 181-182:471-474.
37. Kim R, Emi M, Tanabe K. Caspase-dependent and -independent cell death pathways after DNA damage (Review). Oncol Rep 2005; 14:595-599.
38. Assuncao Guimaraes C, Linden R. Programmed cell deaths. Apoptosis and alternative deathstyles. Eur J Biochem 2004; 271:1638-1650.
39. Yao KC, Komata T, Kondo Y, Kanzawa T, Kondo S, Germano IM. Molecular response of human glioblastoma multiforme cells to ionizing radiation: cell cycle arrest, modulation of the expression of cyclin-dependent kinase inhibitors, and autophagy. J Neurosurg 2003; 98:378-384.
40. Yu L, Alva A, Su H, et al. Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8. Science 2004; 304:1500- 1502.
41. Bredesen DE. Key note lecture: toward a mechanistic taxonomy for cell death programs. Stroke 2007; 38:652-660.
42. Proskuryakov SY, Konoplyannikov AG, Gabai VL. Necrosis: a specific form of programmed cell death? Exp Cell Res 2003; 283:1-16.
43. Festjens N, Vanden Berghe T, Vandenabeele P. Necrosis, a well-orchestrated form of cell demise: signalling cascades, important mediators and concomitant immune response. Biochim Biophys Acta 2006; 1757:1371-1387.
44. Zong WX, Ditsworth D, Bauer DE, Wang ZQ, Thompson CB. Alkylating DNA damage stimulates a regulated form of necrotic cell death. Genes Dev 2004; 18:1272-1282.
45. Coppola S, Nosseri C, Maresca V, Ghibelli L. Different basal NAD levels determine opposite effects of poly(ADP-ribosylpolymerase inhibitors on H2O2-induced apoptosis. Exp Cell Res 1995; 221:462-469.
46. Watson AJ, Askew JN, Benson RS. Poly(adenosine diphosphate ribose) polymerase inhibition prevents necrosis induced by H2O2 but not apoptosis. Gastroenterology 1995; 109:472-482.
47. Borges HL, Hunton IC, Wang JY. Reduction of apoptosis in Rbdeficient embryos via Abl knockout. Oncogene 2007; 26:3868-3877.
48. Borges HL, Chao C, Xu Y, Linden R, Wang JY. Radiation-induced apoptosis in developing mouse retina exhibits dose-dependent requirement for ATM phosphorylation of p53. Cell Death Differ 2004; 11:494-502.
49. Chao C, Herr D, Chun J, Xu Y. Serl 8 and 23 phosphorylation is required for p53-dependent apoptosis and tumor suppression. Embo J 2006; 25:2615-2622.
50. Herzog KH, Chong MJ, Kapsetaki M, Morgan JI, McKinnon PJ. Requirement for Atm in ionizing radiation-induced cell death in the developing central nervous system. Science 1998; 280:1089-1091.
51. Raff MC. Social controls on cell survival and cell death. Nature 1992; 356:397-400.
52. Linden R, Rehen SK, Chiarini LB. Apoptosis in developing retinal tissue. Prog Retin Eye Res 1999; 18:133-165.
53. Ferrer I. The effect of cycloheximide on natural and X-ray-induced cell death in the developing cerebral cortex. Brain Res 1992; 588:351-357.
54. Ferrer I, Serrano T, Rivera R, Olive M, Zujar MJ, Graus F. Radiosensitive populations and recovery in X-ray-induced apoptosis in the developing cerebellum. Acta Neuropathol 1993; 86:491-500.
55. Borges HL, Linden R. Gamma irradiation leads to two waves of apoptosis in distinct cell populations of the retina of newborn rats. J Cell Sci 1999; 112(Pt 23):4315-4324.
56. Lee Y, McKinnon PJ. Responding to DNA double strand breaks in the nervous system. Neuroscience 2007; 145:1365-1374.
57. Mizumatsu S, Monje ML, Morhardt DR, Rola R, Palmer TD, Fike JR. Extreme sensitivity of adult neurogenesis to low doses of X-irradiation. Cancer Res 2003; 63:4021-4027.
58. Fike JR, Rola R, Limoli CL. Radiation response of neural precursor cells. Neurosurg Clin NAm 2007; 18:115-127, x.
59. Jeffers JR, Parganas E, Lee Y, et al. Puma is an essential mediator of p53-dependent and -independent apoptotic pathways. Cancer Cell 2003; 4:321-328.
60. Chong MJ, Murray MR, Gosink EC, et al. Atm and Bax cooperate in ionizing radiation-induced apoptosis in the central nervous system. Proc Natl Acad Sci USA 2000; 97:889-894.
61. Lindsten T, Ross AJ, King A, et al. The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues. Mol Cell 2000; 6:1389-1399.
62. Wei MC, Zong WX, Cheng EH, et al. Proapoptotic BAX, BAK: a requisite gateway to mitochondrial dysfunction and death. Science 2001; 292:727-730.
63. D'Sa C, Klocke BJ, Cecconi F, et al. Caspase regulation of genotoxin-induced neural precursor cell death. J Neurosci Res 2003; 74:435-445.
64. Hahn P, Lindsten T, Lyubarsky A, et al. Deficiency of Bax and Bak protects photoreceptors from light damage in vivo. Cell Death Differ 2004; 11:1192-1197.
65. Takai H, Naka K, Okada Y, et al. Chk2-deficient mice exhibit radioresistance and defective p53-mediated transcription. Embo J 2002; 21:5195-5205.
66. Wu Z, Earle J, Saito S, Anderson CW, Appella E, Xu Y Mutation of mouse p53 Ser23 and the response to DNA damage. Mol Cell Biol 2002; 22:2441-2449.
67. Shieh SY, Ahn J, Tamai K, Taya Y, Prives C. The human homologs of checkpoint kinases Chkl and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites. Genes Dev 2000; 14:289-300.
68. Craig A, Scott M, Burch L, Smith G, Ball K, Hupp T. Allosteric effects mediate CHK2 phosphorylation of the p53 transactivation domain. EMBO Rep 2003; 4:787-792.
69. Liu L, Scolnick DM, Trievel RC, et al. p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage. Mol Cell Biol 1999; 19:1202-1209.
70. Chao C, Saito S, Anderson CW, Appella E, Xu Y. Phosphorylation of murine p53 at ser-18 regulates the p53 responses to DNA damage. Proc Natl Acad Sci USA 2000; 97:11936-11941.
71. Chao C, Wu Z, Mazur SJ, et al. Acetylation of mouse p53 at lysine 317 negatively regulates p53 apoptotic activities after DNA damage. Mol Cell Biol 2006; 26:6859-6869.
72. Lee Y, Chong MJ, McKinnon PJ. Ataxia telangiectasia mutated-dependent apoptosis after genotoxic stress in the developing nervous system is determined by cellular differentiation status. J Neurosci 2001; 21:6687-6693.
73. Linden R, Rehen SK, Chiarini LB, et al. Death in a dish: controls of apoptosis within the developing retinal tissue. Rev Bras Biol 1996; 56(Su 1 Pt 1):89-103.
74. Rehen SK, Neves DD, Fragel-Madeira L, Britto LR, Linden R. Selective sensitivity of early postmitotic retinal cells to apoptosis induced by inhibition of protein synthesis. Eur J Neurosci 1999; 11:4349-4356.
75. Fujita S. Kinetics of cellular proliferation. Exp Cell Res 1962; 28:52-60.
76. Mollinedo F, Gajate C. Fas/CD95 death receptor and lipid rafts: new targets for apoptosis-directed cancer therapy. Drug Resist Updat 2006; 9:51-73.
77. Ferguson TA, Griffith TS. A vision of cell death: Fas ligand and immune privilege 10 years later. Immunol Rev 2006; 213:228-238.
78. Truong T, Sun G, Doorly M, Wang JY, Schwartz MA. Modulation of DNA damage-induced apoptosis by cell adhesion is independently mediated by p53 and c-Abl. Proc Natl Acad Sci USA 2003; 100:10281-10286.
79. Bewick MA, Lafrenie RM. Adhesion dependent signalling in the tumour microenvironment: the future of drug targetting. Curr Pharm Des 2006; 12:2833-2848.